Becton Dickinson Price to Sales Ratio 2010-2023 | BDX

Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of February 27, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-02-26 241.72 3.58
2023-12-31 243.83 $67.61 3.61
2023-09-30 257.48 $67.53 3.81
2023-06-30 262.05 $66.46 3.94
2023-03-31 244.81 $65.67 3.73
2022-12-31 250.51 $65.33 3.83
2022-09-30 218.71 $65.71 3.33
2022-06-30 241.16 $63.87 3.78
2022-03-31 252.91 $63.50 3.98
2021-12-31 238.32 $63.68 3.74
2021-09-30 232.13 $65.36 3.55
2021-06-30 228.93 $63.88 3.58
2021-03-31 228.10 $61.62 3.70
2020-12-31 233.93 $60.36 3.88
2020-09-30 216.78 $57.60 3.76
2020-06-30 222.17 $61.04 3.64
2020-03-31 212.67 $63.37 3.36
2019-12-31 250.87 $63.45 3.95
2019-09-30 232.62 $63.25 3.68
2019-06-30 231.07 $63.21 3.66
2019-03-31 228.24 $62.97 3.62
2018-12-31 205.29 $63.22 3.25
2018-09-30 237.02 $61.44 3.86
2018-06-30 216.91 $58.96 3.68
2018-03-31 195.57 $57.09 3.43
2017-12-31 192.55 $54.93 3.51
2017-09-30 175.65 $56.39 3.11
2017-06-30 174.26 $56.94 3.06
2017-03-31 163.22 $57.36 2.85
2016-09-30 158.58 $57.54 2.76
2016-06-30 149.08 $57.43 2.60
2016-03-31 132.94 $56.14 2.37
2015-12-31 134.32 $56.49 2.38
2015-09-30 115.15 $52.94 2.18
2016-12-31 146.72 $48.61 3.02
2015-06-30 122.41 $46.32 2.64
2015-03-31 123.56 $42.76 2.89
2014-12-31 119.25 $42.99 2.77
2014-09-30 97.11 $42.75 2.27
2014-06-30 100.47 $42.16 2.38
2014-03-31 98.98 $41.54 2.38
2013-12-31 92.97 $41.14 2.26
2013-09-30 83.74 $40.49 2.07
2013-06-30 82.33 $39.35 2.09
2013-03-31 79.24 $38.66 2.05
2012-12-31 64.44 $37.76 1.71
2012-09-30 64.33 $36.66 1.75
2012-06-30 60.86 $35.51 1.71
2012-03-31 62.83 $34.60 1.82
2011-12-31 60.10 $33.93 1.77
2011-09-30 58.61 $33.42 1.75
2011-06-30 68.53 $31.93 2.15
2011-03-31 63.02 $30.88 2.04
2010-12-31 66.55 $29.83 2.23
2010-09-30 58.05 $29.61 1.96
2010-06-30 52.70 $29.83 1.77
2010-03-31 61.03 $29.55 2.07
2009-12-31 60.84 $29.10 2.09
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.833B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.227B 18.26
Cardinal Health (CAH) United States $26.821B 16.12
West Pharmaceutical Services (WST) United States $26.629B 44.96
Align Technology (ALGN) United States $23.807B 47.17
Cooper (COO) United States $18.781B 29.53
Labcorp (LH) United States $18.293B 15.48
Henry Schein (HSIC) United States $10.469B 15.95
DENTSPLY SIRONA (XRAY) United States $7.138B 18.21
Merit Medical Systems (MMSI) United States $4.607B 26.68
Patterson (PDCO) United States $2.683B 12.27
CONMED (CNMD) United States $2.463B 23.21
STAAR Surgical (STAA) United States $1.550B 48.85
Atrion (ATRI) United States $0.623B 29.29
Lifevantage (LFVN) United States $0.090B 14.54
Pro-Dex (PDEX) United States $0.060B 22.67
Biolase (BIOL) United States $0.003B 0.00